Please login to the form below

Not currently logged in
Email:
Password:

GSK strikes deal with Dr. Reddy's

GSK has entered into an agreement with Dr. Reddy's Laboratories to develop and market selected products across an extensive number of emerging markets, excluding India

GlaxoSmithKline (GSK) has entered into an agreement with Dr. Reddy's Laboratories to develop and market selected products across an extensive number of emerging markets, excluding India.

Under the agreement, GSK will gain exclusive access to Dr. Reddy's portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.

The products will be manufactured by Dr. Reddy's and licensed and supplied by GSK in various countries in Africa, the Middle East, Asia Pacific and Latin America.

In certain markets, products will be co-marketed by GSK and Dr. Reddy's. Under the terms of the agreement, revenues will be reported by GSK and shared with Dr. Reddy's as per the agreed terms.

According to GV Prasad, vice chairman and CEO, Dr. Reddy's: "We hope to take our purpose of providing affordable and innovative medicines to a much wider population through this partnership."

Abbas Hussain, president for emerging markets at GSK said: "This is another significant step forward in our strategy to grow and diversify GSK's business in emerging markets."

15th June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics